Literature DB >> 26036009

[Experimental study of the basic pharmacokinetic characteristics of dipeptide carnosine and its efficiency of penetration into brain tissues].

A K Sariev, D A Abaimov, M V Tankevich, E Yu Pantyukhova, D I Prokhorov, T N Fedorova, A V Lopachev, S L Stvolinskii, E V Konovalova, R D Seifulla.   

Abstract

We have used an original chromatography/mass spectrometry technique to study the pharmacokinetics of dipeptide carnosine in C57 Black/6 mice after intra-peritoneal administration of the drug at a dose of 1 g/kg. The basic pharmacokinetic characteristics of carnosine were measured the in the blood and brain. The obtained concentration-time curve has a biexponential character. It is shown that the maximum concentration of carnosine in the blood plasma is Cmax = 1081.75 ± 124.24 μg/mL and it is achieved in a time interval of Tmax = 0.25 h. We showed that i.p. administration of exogenous carnosine could significantly increase the concentration of that substance in the brain. Tissue availability of dipeptide carnosine for brain tissue is relatively good and constitutes 59% from the total amount of blood carnosine. It was found that the maximum concentration of carnosine in the brain occurs at the sixth hour after i.p. administration when the concentration of drug in the blood is minimal.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26036009

Source DB:  PubMed          Journal:  Eksp Klin Farmakol        ISSN: 0869-2092


  3 in total

1.  An assessment of the transport mechanism and intraneuronal stability of L-carnosine.

Authors:  Alexander V Lopachev; Denis A Abaimov; Ivan S Filimonov; Kseniya N Kulichenkova; Tatiana N Fedorova
Journal:  Amino Acids       Date:  2021-10-25       Impact factor: 3.789

Review 2.  Use of Carnosine for Oxidative Stress Reduction in Different Pathologies.

Authors:  V D Prokopieva; E G Yarygina; N A Bokhan; S A Ivanova
Journal:  Oxid Med Cell Longev       Date:  2016-01-24       Impact factor: 6.543

3.  Erythrocytes Prevent Degradation of Carnosine by Human Serum Carnosinase.

Authors:  Henry Oppermann; Stefanie Elsel; Claudia Birkemeyer; Jürgen Meixensberger; Frank Gaunitz
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.